(Q34068034)

English

Experiences in anti-tuberculosis treatment in patients with multiple previous treatments and its impact on drug resistant tuberculosis epidemics

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Experiences in anti-tuberculosis treatment in patients with multiple previous treatments and its impact on drug resistant tuberculosis epidemics (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

0 references

multiple drug resistance

1 reference

based on heuristic

inferred from title

1

object named as

Biao Xu

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

author name string

Qi Zhao

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Yi Hu

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Ying Shi

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Weibing Wang

5

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Vinod K Diwan

6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

publication date

18 August 2014

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Global Health Action

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

24593

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Prevalence and genetic characterization of second-line drug-resistant and extensively drug-resistant Mycobacterium tuberculosis in Rural China

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138495

5 July 2018

Selected culture and drug-susceptibility testing methods for drug-resistant Mycobacterium tuberculosis screening in resource-constrained settings

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138495

5 July 2018

Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138495

5 July 2018

Drug resistance in Mexico: results from the National Survey on Drug-Resistant Tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138495

5 July 2018

Treatment adherence among sputum smear-positive pulmonary tuberculosis patients in mountainous areas in China.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138495

5 July 2018

Multi-drug resistant tuberculosis burden and risk factors: an update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138495

5 July 2018

Extensively drug-resistant tuberculosis: epidemiology and management challenges

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138495

5 July 2018

Adherence to anti-tuberculosis treatment among pulmonary tuberculosis patients: a qualitative and quantitative study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138495

5 July 2018

The epidemiological fitness cost of drug resistance in Mycobacterium tuberculosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138495

5 July 2018

Radiological findings of extensively drug-resistant pulmonary tuberculosis in non-AIDS adults: comparisons with findings of multidrug-resistant and drug-sensitive tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138495

5 July 2018

Prevalence of tuberculosis drug resistance in 10 provinces of China

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138495

5 July 2018

Comparative analysis of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis - epidemiology and predictive factors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138495

5 July 2018

Barriers to accessing TB diagnosis for rural-to-urban migrants with chronic cough in Chongqing, China: a mixed methods study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138495

5 July 2018

Initial drug resistance and tuberculosis treatment outcomes: systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138495

5 July 2018

Multidrug-resistant tuberculosis management in resource-limited settings

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138495

5 July 2018

Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs--worldwide, 2000-2004.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138495

5 July 2018

Progress of DOTS in global tuberculosis control

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138495

5 July 2018

Availability of second-line drugs and anti-tuberculosis drug susceptibility testing in China: a situational analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138495

28 October 2018

Decentralising tuberculosis services from county tuberculosis dispensaries to township hospitals in China: an intervention study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138495

28 October 2018

Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, 1995-2002, after the implementation of DOTS-plus.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138495

28 October 2018

WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138495

28 October 2018

Direct observation and adherence to tuberculosis treatment in Chongqing, China: a descriptive study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138495

28 October 2018

Social behaviour risk factors for drug resistant tuberculosis in mainland China: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25138531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

National survey of drug-resistant tuberculosis in China

1 reference

https://pubmed.ncbi.nlm.nih.gov/25138531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extensively drug-resistant tuberculosis (XDR-TB): recommendations for prevention and control

1 reference

https://pubmed.ncbi.nlm.nih.gov/25138531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

For tuberculosis elimination, Directly Observed Therapy, short course (DOTS) is essential but not sufficient

1 reference

https://pubmed.ncbi.nlm.nih.gov/25138531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DOT in rural China: experience from a case study in Shandong Province, China

1 reference

https://pubmed.ncbi.nlm.nih.gov/25138531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3402/GHA.V7.24593

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34068034&oldid=1990523102"